Atrial fibrillation can have detrimental effects such as stroke, heart failure, and blood clots
Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion
3dg and 3os (vehicle n = 8 mice, 100 nmol kg 1 MK-801 n = 8 mice, 100 nmol kg 1 GLP-1 n = 8 mice, 100 nmol kg 1 GLP-1MK-801 n = 8 mice)
Food and Drug Administration approved Foundayo (orforglipron) for adults with obesity, or for adults who are overweight and have at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol
S.HarrisG
In vivo doseresponse on food intake/body weight in diet-induced obese (DIO) rats In our first preclinical experiment, we performed a dose escalation study in DIO rats to compare responses to treatment with GEP44 and Ex-4